Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations-Reference-Cited by-同舟云学术

Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations

Published:2021-08 Issue:9 Volume:10 Page:973-982
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Zhang Xinyuan¹,Yang Yuching¹,Grimstein Manuela¹,Liu Guansheng¹,Kitabi Eliford¹,Fan Jianghong¹,Wang Ying‐Hong¹,Earp Justin¹,Weaver James L.¹,Zhu Hao¹,Liu Jiang¹,Reynolds Kellie S.¹,Huang Shiew‐Mei¹,Wang Yaning¹

Affiliation:

1. Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Modelling and Simulation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/psp4.12681

Reference23 articles.

1. Connecting Hydroxychloroquine In Vitro Antiviral Activity to In Vivo Concentration for Prediction of Antiviral Effect: A Critical Step in Treating Patients With Coronavirus Disease 2019

2. Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development

3. NDA 021567 atazanavir USPI.https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021567s044 206352s008lbl.pdf. Published 2020. Accessed December 9 2020.

4. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

5. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2;Molecules;2024-09-02

2. Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication;DARU Journal of Pharmaceutical Sciences;2024-07-19

3. More than an Amide Bioisostere: Discovery of 1,2,4-Triazole-containing Pyrazolo[1,5-a]pyrimidine Host CSNK2 Inhibitors for Combatting β-Coronavirus Replication;Journal of Medicinal Chemistry;2024-07-03

4. Novel 1,3-Indanedione-Thiazole Hybrids as Small-Molecule SARS-COV-2 Main Protease Inhibitors With Potential anti-Coronaviral Activity;Polycyclic Aromatic Compounds;2024-03-07

5. Indole-Based Compounds as Potential Drug Candidates for SARS-CoV-2;Molecules;2023-09-13